Imaging of Small Bowel Tumors and Mimics

Abstract

Small bowel tumors are rare with nonspecific and protean clinical presentation. Early diagnosis of small bowel tumors is desirable as they can be associated with significant morbidity. In malignant small bowel tumors, delayed diagnosis may result in dissemination and metastasis leading to poor clinical outcomes. Imaging evaluation of small bowel can be challenging due to unpredictable luminal distension, peristalsis, and motion. In addition, the lack of distinction between the intraluminal lesions and intraluminal contents can be difficult at times. Computed tomography (CT) and magnetic resonance (MR) enterography are the most common imaging techniques for the evaluation of small bowel tumors. While these techniques may not be able to detect small tumors, they provide comprehensive evaluation of lumen, wall, and extramural structures in tumors more than 2 cm. Acquaintance of imaging appearance of common benign and malignant small bowel tumors may allow improved detection during evaluation of CT and MR enterography studies. In this review, we discuss the imaging appearances, approach, and differential diagnosis of small bowel tumors on cross-sectional imaging studies.

Keywords

small bowel - tumors - CT - MRI

Introduction

Small bowel tumors are rare. They comprise 3 to 6% of gastrointestinal tract neoplasms.[1] The diagnosis of small bowel tumors is delayed by the nonspecific nature of the symptoms (abdominal pain, weight loss, gastrointestinal bleeding) and low clinical suspicion.[2] The small bowel neoplasms can present with complications like intussusception, obstruction, and perforation.[3] Thus, early diagnosis is desirable by accurate interpretation of radiologic findings.

The occurrence of small bowel tumors is more in the proximal small bowel in comparison to the distal small bowel.[4] The different segments of the small bowel have predilection for specific histologic subtypes tumors, for example, adenocarcinoma is more common in the duodenum and jejunum, and carcinoid tumor is more common in the ileum.[1] The risk factors for malignant small bowel tumors are alcohol, tobacco, chronic inflammatory diseases including celiac disease and Crohn's disease, human immunodeficiency virus infection, certain foods (e.g., red meat, smoked, salty, and fatty food), and inherited syndromes including Peutz-Jeghers syndrome (PJS), hereditary nonpolyposis colorectal cancer, and familial adenomatous polyposis (FAP).[5] [6] [7] [8] [9]

Benign small bowel tumors comprise 0.5 to 2% of all gastrointestinal neoplasms.[10] Benign small bowel tumors are generally solitary. Multiple tumors are seen in polyposis syndromes.[11] Primary malignant small bowel tumors are less common than benign neoplasms.[4] The malignant small bowel tumors generally have poor prognosis due to delayed presentation. As small bowel can tolerate mild obstruction, patients usually present late when at least two-thirds of the lumen is obstructed.[12]

At imaging, benign small bowel tumors usually appear round and well circumscribed with smooth margins. The malignant tumors have irregular margins with heterogeneous enhancement and may be associated with invasion of adjacent structures.

In general, the imaging detection of small bowel is challenging due to bowel peristalsis, mobility of abdominal structures, respiratory motion, nonuniform distension with luminal agents, and lack of contrast between normal bowel tissue and mass.[13] Plain radiograph has no role in patients with small bowel tumors except when they present in emergency with features of small bowel obstruction and perforation. Ultrasound also has limited role in detection of small bowel tumors. However, in patients at high risk of small bowel tumors like polyposis syndrome, celiac disease, or Crohn's disease, ultrasound evaluation of small bowel may be facilitated by luminal distension using protocols similar to computed tomography enterography (CTE). Barium meal follow through is not considered reliable for the detection of small bower tumors. CT is the widely used modality for imaging of small bowel tumors due to its availability and its speed of acquisition. Furthermore, CT is less susceptible to motion artifacts and provides excellent spatial resolution.[13] However, the ionizing radiation exposure and the need for intravenous iodinated contrast agent are the major limitations of CT. CTE protocol is the preferred technique for suspected small bowel tumors.[14] [15] Patients should have at least 4 to 6 hour fasting status before the study.[16] Oral contrast is administered for adequate distention of the lumen. Neutral oral contrasts are preferred to positive oral contrast.[17] These provide better delineation of mucosal enhancement, mural thickness, and mesenteric vasculature.[18] A few studies have evaluated a novel CT technique employing carbon dioxide instillation (virtual CT endoscopy) for the evaluation of small bowel lesions including tumors.[19] [20] MR enterography is an alternative to CTE. The key benefit of MR enterography is the absence of ionizing radiation. This makes MRI particularly attractive for imaging in children and for repeat examination. However, the limitations include long acquisition time, limited availability, and a relative higher cost.[21]

In comparison to cross-sectional imaging, endoscopy (or enteroscopy) and capsule endoscopy are better for the detection of small intraluminal tumors.[15] However, a study reported better sensitivity of CTE over capsule endoscopy for the detection of submucosal lesions.[22] Though with the current state of the art endoscopy techniques, the entire small bowel can be evaluated, endoscopic techniques do not provide information regarding the extramural extent of the diseases.[3] [13] The various imaging techniques utilized in evaluation of small bowel tumors are listed in [Table 1]. The various benign and malignant small bowel tumors are mentioned in [Table 2].

Table 1 Various diagnostic modalities for small bowel tumors

Endoluminal (invasive/semi-invasive)	Radiological (noninvasive)
	Fluoroscopic	Cross-sectional imaging
Upper GI endoscopy Colonoscopy Push enteroscopy Balloon enteroscopy Balloon enteroscopy Endoscopic ultrasound Capsule endoscopy	SBFT SBE	CT enterography MR enterography PET-CT PET-CT Enterography Virtual CT Endoscopy

Abbreviations: CT, computed tomography; MR, magnetic resonance; GI, gastrointestinal; PET-CT, positron emission tomography-computed tomography; SBE, small bowel enteroclysis; SBFT, small bowel follow through.

Table 2 Various benign and malignant small bowel tumors

Benign	Malignant
Lipoma Polyp Leiomyoma Gastrointestinal stromal tumor (GIST) Inflammatory fibroid polyp Hemangioma	Adenocarcinoma Lymphoma Neuroendocrine tumor Malignant GIST Metastasis Gastrointestinal Neuroectodermal tumors

Benign Small Bowel Tumors

Lipoma

Despite being a rare tumor, small bowel lipoma is the most common benign lesion of the bowel causing intussusception in adults. Lipoma arises from submucosa and consists of mature adipose tissue surrounded by a thin capsule. Lipoma is usually sessile; however, it can be pedunculated. Almost 50% of lipomas are found in the ileum, and less than 50% of patients with small bowel lipoma are symptomatic.[23] Lesions more than 2 cm in diameter can be symptomatic and may cause bowel obstruction or gastrointestinal bleeding.[24] Small bowel lipoma has no malignant potential.

On gastrointestinal contrast studies, lipomas have characteristic appearance and demonstrate mobility. They produce a solitary smooth intraluminal filling defect. They demonstrate a pseudopedicle at their tip.[25] CT and MRI features are diagnostic. A well-defined homogeneous mass with fat attenuation (−40 to −120 HU) on CT is seen ([Fig. 1]).[12] The MRI findings of small bowel lipoma include homogeneous signal intensity corresponding to macroscopic fat without contrast enhancement.[13]

Fig. 1 Lipoma: Axial (A) and coronal sections (B) of contrast-enhanced computed tomography abdomen showing a well-defined fat attenuation lesion in second part of duodenum (white arrows).

Polyp

Polyps comprise one-fifth of the benign small bowel neoplasms.[26] Polyps generally are asymptomatic. However, polyps can lead to obstruction or intussusception when they grow large enough. Pathologic subtypes are hamartomatous, hyperplastic, adenomatous, and inflammatory.[13] Polyps can be solitary or multiple. Numerous polyps are seen in inherited syndromes ([Fig. 2]). Polyps appear as small (<2 cm), homogenously enhancing masses which protrude into the bowel lumen.[11] The adenomatous subtype has increased risk of malignant transformation and is associated with polyposis syndromes. Adenomatous polyps are seen in patients with FAP. Hamartomatous polyps are associated with juvenile polyposis syndrome, PJS, and Cowden syndrome.[27] Cronkhite–Canada syndrome is an acquired nonfamilial polyposis syndrome that is characterized by gastrointestinal polyposis, onycholysis, cutaneous pigmentation, and alopecia.[28] The risk of malignant transformation is higher for tumors more than 1 cm.[23] Size greater than 2 cm and extraserosal extension are highly suggestive of malignant degeneration within a polyp.[29]

Fig. 2 Polyps: (A) Endoscopic image showing multiple polyps and (B) involvement of fingernails in Cronkhite-Canada syndrome; (C) Axial computed tomography (CT) enterography showing well-defined round homogenously enhancing polyp in the jejunal lumen (arrow); (D) Circumoral muco-cutaneous pigmentation; (E) Barium meal follow through showing round filling defects (consistent with polyps) in the antrum of stomach (arrows) and (F) Coronal CT enterography section showing multiple enhancing polyps within the small and large bowel (arrows).

Leiomyoma

Leiomyoma is a rare tumor. It is more common in the jejunum than the ileum.[30] Clinical presentation is due to tumor ulceration and bleeding, causing abdominal pain, gastrointestinal bleeding, and chronic anemia. At CT and MRI, it appears as a well-defined homogeneously enhancing mass. Calcification and ulceration may occur in larger tumors.[31] Imaging features may be indistinguishable from gastrointestinal stromal tumor (GIST). Larger tumors (>6 cm) with irregular margins and lymphadenopathy should cause suspicion for malignancy.[30]

GIST

GISTs are the most frequent mesenchymal tumor arising from gastrointestinal tract.[32] More than one-third of the GISTs arise in the small bowel. They are more common in the proximal small bowel.[33] GISTs arise from the interstitial cells of Cajal and are characterized by c-KIT (CD117) expression.[32] Other mutations include platelet derived growth factor receptor α, succinate dehydrogenase, v-raf murine sarcoma viral oncogene homolog B1, and neurofibromatosis type 1.[33] They tend to have a wide spectrum of clinical behavior, ranging from benign tumors (which are incidentally discovered) to malignant lesions with considerable overlap in the imaging and microscopic features of both entities.[34] All GISTs are potentially malignant.[35] [36]

At imaging, benign GISTs are indistinguishable from other mesenchymal tumors. They are well-circumscribed lesions with a variable enhancement pattern. They commonly extend exophytically from the bowel lumen. Calcification is a rare finding ([Fig. 3]).[37] Smaller lesions (< 2cm) appear as hyper-enhancing lesions. With increasing size, there is development of necrosis in the tumor core. Larger lesions thus appear as heterogeneously enhancing cavitating lesions. Although imaging features may not be entirely reliable for distinguishing benign and malignant GISTs, larger masses with necrosis, local invasion, and hemorrhage suggest malignant behavior.[38] Metastases in such cases commonly occur to the liver, omentum, or peritoneum ([Fig. 4]). Significant lymphadenopathy is not seen in these cases and favors other malignant neoplasms like lymphoma or metastatic disease. The prognosis of GIST depending upon CT features is mentioned in [Table 3].

Fig. 3 Gastrointestinal stromal tumors: (A) Hypervascular intraluminal mass (arrow) in the D-J flexure/proximal jejunum; (B, C): necrotic tumor involving distal jejunum on computed tomography (CT; arrow in B) and ultrasound (arrow in C); (D) Axial contrast-enhanced CT abdomen showing hypoenhancing exophytic mass lesion arising from stomach with multiple foci of calcification; (E and F) Axial and coronal images showing endophytic jejunal gastrointestinal stromal tumor.

Fig. 4 Malignant gastrointestinal stromal tumor: (A) Multiple liver metastases are seen (arrows). The cystic appearance of these lesions is due to imatinib therapy. (B) Marked peritoneal thickening and nodularity (arrows) secondary to peritoneal metastases is seen.

Table 3 Prognostic features of GIST on imaging

CT features	Prognosis
Site Stomach Duodenum Ileum/jejunum	Favorable Intermediate Unfavorable
Size <5cm 5–10 cm >10 cm	Favorable Intermediate Unfavorable
Margin Regular Irregular	Favorable Unfavorable
Homogeneous enhancement	Favorable
Hemorrhage	Unfavorable
Necrosis/cystic degeneration	Unfavorable
Air	Unfavorable

Abbreviations: CT, computed tomography; GIST, gastrointestinal stromal tumor.

Treatment for resectable GISTs is wide local excision. Systemic treatment in the form of chemotherapy is often administered. Imaging features of GISTs change post-imatinib therapy and include intralesional hemorrhage, cystic degeneration of tumor, and development of ascites.[39] The radiologist must thus be aware of these changes and always acquire a multiphasic CT following a noncontrast scan in follow-up patients with GIST on chemotherapy.[39]

Hemangioma

These rare submucosal tumors occur more commonly in the jejunum. They may be sessile or pedunculated.[40] On CT, hemangioma appears as enhancing, intraluminal polypoid mass. On MR, hemangiomas show marked T2-weighted hyperintensity with avid nodular enhancement in the arterial phase.[41] The enhancement is retained in the delayed phase.

Malignant Small Bowel Neoplasms

Adenocarcinoma

Adenocarcinoma accounts for 25 to 40% of primary malignant tumors of the small bowel.[42] [43] Proximal jejunum or distal duodenum is the most involved sits.[44] Presentation may be nonspecific or related to malignancy-induced gastrointestinal bleeding or obstruction.

CT appearances include circumferential annular (apple core) mural thickening or eccentric and irregular mass with luminal narrowing ([Fig. 5]).[45] There may be extension into adjacent fat, vascular invasion, lymphadenopathy, peritoneal and distant metastases (most often to the liver).

Fig. 5 Adenocarcinoma: (A) Coronal computed tomography (CT) enterography image showing asymmetric enhancing mural thickening (arow) involving distal jejunum causing intestinal obstruction; (B, C): Coronal and axial CT enterography image showing asymmetric mural thickening involving the duodenum with adjacent invasion (arrow in B) and necrotic retroperitoneal lymph nodes (arrow in C); (D, E): Enteroscopic images showing intraluminal polypoidal (D) and annular growth patterns (E).

Neuroendocrine Tumor

Gastrointestinal neuroendocrine tumors (GNET) originate from the enterochromaffin cells within the gastro-entero-pancreatic system.[34] These are the second most common malignant tumors of the small bowel (20–25% of malignant tumors).[46] One-third of GNETs originate from the small bowel.[47] Ileum is the most common site of involvement. The characteristic appearance of small bowel GNET is a well-defined solitary avidly enhancing mural mass ([Fig. 6]). Smaller lesion may be missed on CT. MRI may allow detection of some of these lesions due to better soft tissue resolution. Multiple GNETs occur in one-fourth of the patients ([Fig. 6]).[48] Carcinoid tumors may cause asymmetric or nodular mural thickening. The key to correct diagnosis in these cases is the identification of spiculated (due to desmoplastic reaction caused by secretion of serotonin) calcified mesenteric lesion with or without liver metastases.[49] [50] Mesenteric involvement by direct extension or via lymphatics occurs in approximately 40 to 80% of the cases. Mesenteric metastases calcify in 70% of the cases.[49] Differential diagnoses include treated lymphoma or retractile mesenteritis. Somatostatin-analog imaging exams have an important role both in diagnosis and staging ([Fig. 6]). In-pentetreotide imaging (Octreoscan) has now been replaced by newer analogue agents such as 18F-FDOPA and 68Ga-DOTATATE.[51]

Fig. 6 Neuroendocrine tumor: (A) Solitary hypervascular lesion within the duodenal lumen (arrow); (B) Coronal image showing multiple neuroendocrine tumors (NETs) in the stomach (white arrows) and hypervascular lymph nodes (double headed white arrows), (C) Hypervascular NET in the duodenum with calcifications (arrow) with liver metastasis (dashed arrow); (D, E): Somatostatin analogue positron emission tomography images showing avid lesions in the mesentery (arrow); (F) Computed tomography enterography image showing spiculated hypoenhancing mesenteric mass lesion (arrow).

Lymphoma

Primary gastrointestinal lymphoma is the most common form of extranodal lymphoma.[52] Diagnosis can be ascertained by the lack of peripheral or mediastinal lymphadenopathy, normal white blood cell count, and differential leucocyte count without the involvement of liver or spleen.[53] Ileum is the most common site of involvement due to abundant lymphoid tissue ([Fig. 7]). Lymphoma of the small bowel is categorized into five forms: pseudoaneurysmal, polypoid, endoexoenteric, stenosing, and mesenteric ([Fig. 7]).[54] The most common type of small bowel lymphoma is the polypoidal form with single or multiple polypoidal lesions protruding into the lumen.[55] This type of lymphoma may act as a lead point for intussusception. The pseudoaneurysmal form involves the submucosa and muscularis layers causing mass-like mural thickening. The lack of obstruction is due to complete replacement of the muscle layer with lymphoid tissue.[54] The endoexoenteric form or the cavitatory form produces a large soft-tissue mass communicating with the bowel lumen producing a characteristic air-contrast contrast material level. Malignant GIST may produce a similar appearance.[12] The stenosing form of lymphoma is uncommon. It is usually encountered in patients with celiac disease. This form occurs most commonly in the distal duodenum.[12] In the mesenteric form, tumor extends into the mesentery from the bowel wall.

Fig. 7 Lymphoma: (A–C): Coronal computed tomography enterography images showing heterogeneously enhancing lesion in relation to terminal ileum (arrow). B: Asymmetric wall thickening involving terminal ileum (arrow); C: Circumferential mural thickening causing luminal stenosis in proximal ileum (arrow); D: Asymmetric mural thickening with exophytic component in terminal ileum (arrow); E: Ileo-colic intussusception secondary to lymphoma (arrow).

Immunophenotypically, lymphomas are of two types: B-cell and T-cell lymphoma. B-cell lymphoma (diffuse large B-cell lymphoma) is the most common type and is usually present is ileum, whereas T-cell lymphoma is usually associated with celiac disease and is present commonly in jejunum and proximal ileum.[55] T-cell lymphoma is generally multifocal and may be associated with complication like perforation.

On barium meal follow through, there is irregular wall thickening, fold effacement, aneurysmal bowel dilatation, single, or multiple filling defects due to polypoid masses. At CT and MRI, the imaging appearance of small bowel lymphoma parallels the morphological forms described above. Extensive regional and distant adenopathy help in confirming the diagnosis and from other neoplasms.

Differentiating lymphoma from primary adenocarcinoma can be challenging. The features favoring lymphoma are distal site of involvement (ileum), marked homogeneous wall thickening usually greater than 2 cm, multifocal involvement, and extensive lymphadenopathy.[12]

Metastasis

Metastasis to the small bowel is rare. Melanoma, lung cancer, and breast cancer are the tumors that may show small bowel spread.[29] Small bowel metastases may be solitary or multiple with a variety of appearances. At one end of the spectrum, they can mimic benign lesions with discrete, smoothly marginated nodules showing homogenous enhancement. At the other end, there are large mass with cavitation, invasion of adjacent structures, and intraperitoneal spread ([Fig. 8]).[56] [57] Metastases must be suspected when a solid small bowel mass is seen in a patient with malignancy known to metastasize to bowel.

Fig. 8 Small bowel metastases: (A) Multiple enhancing serosal deposits in a case of ovarian cancer; (B) Enteroscopic image showing intraluminal polypoidal hemorrhagic soft tissue mass in jejunum in a patient with choriocarcinoma.

Mass-Like Small Bowel Lesions: Small Bowel Tumor Mimics ([Fig. 9])

Fig. 9 Neoplasms mimics: (A) Jejunal diverticulitis (arrow); (B, C): Dilated terminal ileum with mural thickening (B, arrow) and mural thickening involving cecum with dilated terminal ileum (C, arrow) in a patient with ileocecal tuberculosis; (D) Mural thickening involving jejunal loops in a patient with Henoch–Schonlein purpura.

Small Bowel Diverticulitis

Other than duodenal or Meckel's diverticulitis, small bowel diverticulitis is rare. Jejunum is more commonly involved.[58] On CT, there is a thick-walled well-defined mass-like structure containing intestinal contents (debris, fecal material, and gas). There is associated bowel wall thickening and mesenteric fat stranding. In some patients, additional diverticulitis may also be seen at other sites.[59] [60]

Meckel's Diverticulum

Meckel's diverticulum is associated with several complications including diverticulitis, perforation, enterolith formation, bowel obstruction, bleeding from ectopic gastric mucosa, and neoplasm.[61] On CT, Meckel's diverticulum may be confused for a bowel origin mass, but evaluation of serial thin sections reveals a visualized as a blind-ending, fluid, or debris-filled, dilated mass-like structure in continuity with the ileum. CT enterography has higher sensitivity in evaluating Meckel's diverticulum.[62]

Small Bowel Hematoma

Small bowel hematoma occurs in the setting of anticoagulation, coagulopathies, vasculitis, trauma, and malignancy.[63] [64] On CT, the thickened bowel shows mural hyperattenuation, and luminal narrowing.[12] The mural hyperattenuation in acute phase helps in the differentiation of small bowel hematoma from other causes of bowel wall thickening.[65] With aging of the hematoma, the hyperdensity of the bowel may disappear. Complete resolution of hematoma occurs over a few weeks.

The other differential diagnoses of small bowel tumors are mentioned in [Table 4].

Table 4 Differential diagnosis for small bowel tumor

Intramural hematoma	Anticoagulation, coagulopathy, trauma, vasculitis, mass-like, mural hyperattenuation with luminal narrowing; spontaneous resolution
Small bowel diverticulitis	Elderly patients, jejunum, ovoid, mass-like structure containing air, fluid, lesion with adjacent fat standing
Meckel's diverticulitis	Mass-like structure in continuity with small bowel
Eosinophilic gastroenteritis	Nodular/Irregular focal, segmental or diffuse thickening vs. lymphoma
Giardiasis/Whipple's disease	Fold thickening in duodenum and proximal jejunum
Localized lymphangiectasia	Low attenuation wall thickening of jejunum
Sclerosing mesenteritis	versus carcinoid

Conclusion

Imaging plays an important role in the detection and characterization of small bowel tumors. It is important to be aware of lesions that can mimic small bowel tumors as they have entirely different management.

Conflict of Interest

None declared.

• References

• 1 Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998; 7 (03) 243-251
• 2 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (01) 7-30
• 3 Masselli G, Guida M, Laghi F, Polettini E, Gualdi G. Magnetic resonance of small bowel tumors. Magn Reson Imaging Clin N Am 2020; 28 (01) 75-88
• 4 Buckley JA, Fishman EK. CT evaluation of small bowel neoplasms: spectrum of disease. Radiographics 1998; 18 (02) 379-392
• 5 Chow WH, Linet MS, McLaughlin JK, Hsing AW, Chien HT, Blot WJ. Risk factors for small intestine cancer. Cancer Causes Control 1993; 4 (02) 163-169
• 6 Wu AH, Yu MC, Mack TM. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer 1997; 70 (05) 512-517
• 7 Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 2002; 45 (11) 1496-1502
• 8 Rodriguez-Bigas MA, Vasen HF, Lynch HT. et al; International Collaborative Group on HNPCC. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. Cancer 1998; 83 (02) 240-244
• 9 Giardiello FM, Brensinger JD, Tersmette AC. et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119 (06) 1447-1453
• 10 Gourtsoyianni S, Papanikolaou N. Small Bowel Benign Neoplasms and Polyposis. In: Hamm B, Ros PR. eds. Abdominal Imaging. Berlin, Germany: Springer; 2013: 593-602
• 11 Masselli G, Colaiacomo MC, Marcelli G. et al. MRI of the small-bowel: how to differentiate primary neoplasms and mimickers. Br J Radiol 2012; 85 (1014): 824-837
• 12 Jasti R, Carucci LR. Small bowel neoplasms: a pictorial review. Radiographics 2020; 40 (04) 1020-1038
• 13 Williams EA, Bowman AW. Multimodality imaging of small bowel neoplasms. Abdom Radiol (NY) 2019; 44 (06) 2089-2103
• 14 Hara AK, Leighton JA, Sharma VK, Heigh RI, Fleischer DE. Imaging of small bowel disease: comparison of capsule endoscopy, standard endoscopy, barium examination, and CT. Radiographics 2005; 25 (03) 697-711 , discussion 711–718 Jung Wan Han
• 15 Han JW, Hong SN, Jang HJ. et al. Clinical efficacy of various diagnostic tests for small bowel tumors and clinical features of tumors missed by capsule endoscopy. Gastroenterol Res Pract 2015; 2015: 623208-623214
• 16 Sokhandon F, Al-Katib S, Bahoura L, Copelan A, George D, Scola D. Multidetector CT enterography of focal small bowel lesions: a radiological-pathological correlation. Abdom Radiol (NY) 2017; 42 (05) 1319-1341
• 17 Paulsen SR, Huprich JE, Fletcher JG. et al. CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 2006; 26 (03) 641-657 , discussion 657–662
• 18 Gauci J, Sammut L, Sciberras M. et al. Small bowel imaging in Crohn's disease patients. Ann Gastroenterol 2018; 31 (04) 395-405
• 19 Dohan A, Boudiaf M, Dray X. et al. Detection of small-bowel tumours with CT enteroclysis using carbon dioxide and virtual enteroscopy: a preliminary study. Eur Radiol 2018; 28 (01) 206-213
• 20 Kalra N, Gulati A, Gupta P. et al. Comparison of virtual computed tomography enteroscopy using carbon dioxide with small-bowel enteroclysis and capsule endoscopy in patients with small-bowel tuberculosis. Eur Radiol 2021; 31 (05) 3297-3305
• 21 Mollard BJ, Smith EA, Dillman JR. Pediatric MR enterography: technique and approach to interpretation-how we do it. Radiology 2015; 274 (01) 29-43
• 22 Hakim FA, Alexander JA, Huprich JE, Grover M, Enders FT. CT-enterography may identify small bowel tumors not detected by capsule endoscopy: eight years experience at Mayo Clinic Rochester. Dig Dis Sci 2011; 56 (10) 2914-2919
• 23 Spada C, Alfieri S, Barbaro B, Familiari P, Minelli Grazioli L, Costamagna G. Giant lipoma as an unusual cause of obscure gastrointestinal bleeding. Video J Encyclopedia GI Endosc 2013; 1 (01) 233-234
• 24 de Latour RA, Kilaru SM, Gross SA. Management of small bowel polyps: a literature review. Best Pract Res Clin Gastroenterol 2017; 31 (04) 401-408
• 25 Gourtsoyiannis NC, Bays D. Primary tumours of the small intestine. In: Gourtsoyiannis NC, Ros PR. eds. Radiologic - Pathologic Correlations from Head to Toe. Berlin, Germany: Springer; 2005: 273-289
• 26 Sailer J, Zacherl J, Schima W. MDCT of small bowel tumours. Cancer Imaging 2007; 7 (01) 224-233
• 27 Katabathina VS, Menias CO, Khanna L. et al. Hereditary gastrointestinal cancer syndromes: role of imaging in screening, diagnosis, and management. Radiographics 2019; 39 (05) 1280-1301
• 28 Sweetser S, Boardman LA. Cronkhite-Canada syndrome: an acquired condition of gastrointestinal polyposis and dermatologic abnormalities. Gastroenterol Hepatol (N Y) 2012; 8 (03) 201-203
• 29 Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol 2001; 33 (04) 267-282
• 30 Gourtsoyiannis NC, Bays D, Malamas M, Barouxis G, Liasis N. Radiological appearances of small intestinal leiomyomas. Clin Radiol 1992; 45 (02) 94-103
• 31 Ramai D, Tan QT, Nigar S, Ofori E, Etienne D, Reddy M. Ulcerated gastric leiomyoma causing massive upper gastrointestinal bleeding: A case report. Mol Clin Oncol 2018; 8 (05) 671-674
• 32 Danti G, Addeo G, Cozzi D. et al. Relationship between diagnostic imaging features and prognostic outcomes in gastrointestinal stromal tumors (GIST). Acta Biomed 2019; 90 (5-S): 9-19
• 33 Ricci R. Syndromic gastrointestinal stromal tumors. Hered Cancer Clin Pract 2016; 14: 15
• 34 Miettinen M, Lasota J. Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438 (01) 1-12
• 35 Inoue A, Ota S, Nitta N. et al. Difference of computed tomographic characteristic findings between gastric and intestinal gastrointestinal stromal tumors. Jpn J Radiol 2020; 38 (08) 771-781
• 36 Crosby JA, Catton CN, Davis A. et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol 2001; 8 (01) 50-59
• 37 Peng F, Liu Y. Gastrointestinal stromal tumors of the small intestine: progress in diagnosis and treatment research. Cancer Manag Res 2020; 12: 3877-3889
• 38 Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 2003; 23 (02) 283-304 , 456, quiz 532
• 39 Dimitrakopoulou-Strauss A, Ronellenfitsch U, Cheng C. et al. Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review. Clin Transl Imaging 2017; 5 (03) 183-197
• 40 Kim SW, Kim HC, Oh J, Won KY, Park SJ, Yang DM. Tumors of the jejunum and ileum: a pattern-based imaging approach on CT. Abdom Radiol (NY) 2019; 44 (07) 2337-2345
• 41 d'Almeida M, Jose J, Oneto J, Restrepo R. Bowel wall thickening in children: CT findings. Radiographics 2008; 28 (03) 727-746
• 42 Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 2005; 16 (07) 781-787
• 43 Nelson RL. Adenocarcinoma of the small intestine. In: Nelson RL, Nyhus LM. eds. Surgery of the Small Intestine. Norwalk, Conn: Appleton & Lange; 1988: 223-230
• 44 Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surg 1984; 147 (01) 66-71
• 45 Gore RM, Mehta UK, Berlin JW, Rao V, Newmark GM. Diagnosis and staging of small bowel tumours. Cancer Imaging 2006; 6 (01) 209-212
• 46 Mantzoros I, Savvala NA, Ioannidis O. et al. Midgut neuroendocrine tumor presenting with acute intestinal ischemia. World J Gastroenterol 2017; 23 (45) 8090-8096
• 47 Anzidei M, Napoli A, Zini C, Kirchin MA, Catalano C, Passariello R. Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects. Br J Radiol 2011; 84 (1004) 677-690
• 48 Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist 2008; 13 (12) 1255-1269
• 49 Burke AP, Thomas RM, Elsayed AM, Sobin LH. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 1997; 79 (06) 1086-1093
• 50 Horton KM, Kamel I, Hofmann L, Fishman EK. Carcinoid tumors of the small bowel: a multitechnique imaging approach. AJR Am J Roentgenol 2004; 182 (03) 559-567
• 51 Addeo P, Bachellier P, Goichot B. et al. Preoperative imaging with 18F-FDOPA PET/CT for small bowel neuroendocrine tumours. J Gastrointest Surg 2018; 22 (04) 722-730
• 52 Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 1961; 49 (213) 80-89
• 53 Domizio P, Owen RA, Shepherd NA, Talbot IC, Norton AJ. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol 1993; 17 (05) 429-442
• 54 Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980; 46 (01) 215-222
• 55 McLaughlin PD, Maher MM. Primary malignant diseases of the small intestine. AJR Am J Roentgenol 2013; 201 (01) W9-14
• 56 Kim SY, Kim KW, Kim AY. et al. Bloodborne metastatic tumors to the gastrointestinal tract: CT findings with clinicopathologic correlation. AJR Am J Roentgenol 2006; 186 (06) 1618-1626
• 57 O'Riordan BG, Vilor M, Herrera L. Small bowel tumors: an overview. Dig Dis 1996; 14 (04) 245-257
• 58 Kam MH, Barben CP, Eu KW, Seow-Choen F. Small bowel malignancies: a review of 29 patients at a single centre. Colorectal Dis 2004; 6 (03) 195-197
• 59 Coulier B, Maldague P, Bourgeois A, Broze B. Diverticulitis of the small bowel: CT diagnosis. Abdom Imaging 2007; 32 (02) 228-233
• 60 Kassir R, Boueil-Bourlier A, Baccot S. et al. Jejuno-ileal diverticulitis: Etiopathogenicity, diagnosis and management. Int J Surg Case Rep 2015; 10: 151-153
• 61 Novak JS, Tobias J, Barkin JS. Nonsurgical management of acute jejunal diverticulitis: a review. Am J Gastroenterol 1997; 92 (10) 1929-1931
• 62 Kusumoto H, Yoshida M, Takahashi I, Anai H, Maehara Y, Sugimachi K. Complications and diagnosis of Meckel's diverticulum in 776 patients. Am J Surg 1992; 164 (04) 382-383
• 63 Segaul AI, Mills M, Wertheimer HM. Intramural hematoma of the small intestine as a complication of anticoagulant therapy. Am J Surg 1964; 107 (06) 891-894
• 64 Kahn A, Vandenbogaert N, Cremer N, Fondu P. Intramural hematoma of the alimentary tract in two hemophilic children. Helv Paediatr Acta 1977; 31 (06) 503-507
• 65 Balthazar EJ, Hulnick D, Megibow AJ, Opulencia JF. Computed tomography of intramural intestinal hemorrhage and bowel ischemia. J Comput Assist Tomogr 1987; 11 (01) 67-72

Publication History

Article published online:
10 July 2023